Ke‐He Ruan

ORCID: 0000-0001-7694-4452
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory mediators and NSAID effects
  • Receptor Mechanisms and Signaling
  • Eicosanoids and Hypertension Pharmacology
  • Monoclonal and Polyclonal Antibodies Research
  • Neuropeptides and Animal Physiology
  • Peroxisome Proliferator-Activated Receptors
  • Pharmacogenetics and Drug Metabolism
  • Chemical Synthesis and Analysis
  • Estrogen and related hormone effects
  • Nicotinic Acetylcholine Receptors Study
  • Cancer, Hypoxia, and Metabolism
  • Pulmonary Hypertension Research and Treatments
  • Sexual function and dysfunction studies
  • Protein purification and stability
  • Microbial Natural Products and Biosynthesis
  • Steroid Chemistry and Biochemistry
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Nitric Oxide and Endothelin Effects
  • Enzyme Structure and Function
  • Urinary Bladder and Prostate Research
  • Angiogenesis and VEGF in Cancer
  • Adenosine and Purinergic Signaling
  • Peptidase Inhibition and Analysis
  • Synthesis of β-Lactam Compounds
  • Metal-Catalyzed Oxygenation Mechanisms

University of Houston
2014-2023

Miyazaki Welfare Medical College
2015

The University of Texas Health Science Center at Houston
1995-2013

University of Liège
2006

The University of Texas System
2003

The University of Texas at Austin
1997

University of Miyazaki
1984-1987

Overexpression and activation of the murine double minute 2 (MDM2) or nuclear factor activated T cells 1 (NFAT1) oncoproteins frequently occur in pancreatic cancer. Most MDM2 inhibitors under development target MDM2-p53 binding have little no effect on cancers without functional p53, including Some available compounds indirectly inhibit NFAT1 activity by interfering with calcineurin activity, but there are currently specific against NFAT1. Here we performed a high-throughput virtual...

10.1158/0008-5472.can-17-3939 article EN Cancer Research 2018-09-14

Background— Intravenous prostacyclin is approved for treating pulmonary arterial hypertension (PAH), but it has a short half-life and must be delivered systemically via an indwelling intravenous catheter. We hypothesize that localized jugular vein delivery of prostacyclin-producing cells may provide sustained therapeutic effects without the limitations systemic delivery. Methods Results— generated vector expressing human cyclooxygenase isoform 1 synthase fusion protein produces from...

10.1161/circulationaha.113.003139 article EN Circulation 2013-07-11

Abstract Promoting the paracrine effects of human mesenchymal stem cell (hMSC) therapy may contribute to improvements in patient outcomes. Here we develop an innovative strategy enhance hMSCs. In a mouse hindlimb ischaemia model, examine hMSCs which novel triple-catalytic enzyme is introduced stably produce prostacyclin (PGI 2 -hMSCs). We show that PGI -hMSCs facilitate perfusion recovery and running capability as compared with control or iloprost (a stable analogue). Transplanted do not...

10.1038/ncomms11276 article EN cc-by Nature Communications 2016-04-15

Thromboxane A2 receptor (TP receptor), a prostanoid receptor, belongs to the G protein-coupled family, composed of three intracellular loops and extracellular connecting seven transmembrane helices. The highly conserved domains receptors were found in second loop (eLP2), which was proposed be involved ligand recognition. 3D structure eLP2 would help further explain binding mechanism. Analysis human TP model generated from molecular modeling based on bacteriorhodopsin crystallographic...

10.1021/bi001867c article EN Biochemistry 2000-12-07

Cyclooxygenase isoform-2 (COX-2) and microsomal prostaglandin E2 synthase-1 (mPGES-1) are inducible enzymes that become up-regulated in inflammation some cancers. It has been demonstrated their coupling reaction of converting arachidonic acid (AA) into (PG) (PGE2) is responsible for Understanding reactions at the molecular cellular levels a key step toward uncovering pathological processes inflammation. In this paper, we describe structure-based enzyme engineering which produced novel hybrid...

10.1093/protein/gzp058 article EN Protein Engineering Design and Selection 2009-10-22

Salicylic acid (SA), an endogenous signaling molecule of plants, possesses anti-inflammatory and anti-neoplastic actions in human. Its derivative, aspirin, is the most commonly used analgesic drug. Aspirin sodium salicylate (salicylates) have been reported to multiple pharmacological actions. However, it unclear whether they bind a cellular protein. Here, we report for first time purification from human fibroblasts approximately 78 kDa binding protein with sequence identity immunoglobulin...

10.1096/fj.01-0259com article EN The FASEB Journal 2001-11-01

The second extracellular loop (eLP2) of the thromboxane A(2) receptor (TP) had been proposed to be involved in ligand binding. Through two-dimensional (1)H NMR experiments, overall three-dimensional structure a constrained synthetic peptide mimicking eLP2 determined by our group (Ruan, K.-H., So, S.-P., Wu, J., Li, D., Huang, A., and Kung, J. (2001) Biochemistry 40, 275-280). To further identify residues binding, TP antagonist, SQ29,548 was used interact with peptide. High resolution NOESY,...

10.1074/jbc.m209337200 article EN cc-by Journal of Biological Chemistry 2003-03-01

Prostacyclin (PGI2), a vascular protector with vasodilation and antithrombotic properties, is synthesized by coupling reactions of cyclooxygenase (COX, the first enzyme) PGI2 synthase (PGIS, second using arachidonic acid (AA) as an initial substrate. The COX product, prostaglandin H2 (PGH2) also command substrate for other prostanoid enzymes that produce distinct eicosanoids, such thromboxane A2 (TXA2). actions TXA2 to cause vasoconstriction platelet aggregation oppose vasodilatory...

10.1021/bi0614277 article EN Biochemistry 2006-11-01

Abstract Background Conventionally the active ingredients in herbal extracts are separated into individual components, by fractionation, desalting, and followed high-performance liquid chromatography (HPLC). In this study we have tried to directly screen water-soluble fractions of herbs with potential before purification or extraction. We propose that mimicking prostaglandin E 1 (PGE ) 2 can be identified non-purified fraction. PGE is a potent anti-inflammatory molecule used for treating...

10.1186/1472-6882-11-11 article EN cc-by BMC Complementary and Alternative Medicine 2011-02-07

Prostacyclin (PGI2) is a key vascular protector, metabolized from endogenous arachidonic acid (AA). Its actions are mediated through the PGI2 receptor (IP) and nuclear receptor, peroxisome proliferator-activated γ (PPARγ). Here, we found that involved in regulating cellular microRNA (miRNA) expression its receptors mouse adipose tissue-derived primary culture cell line expressing novel hybrid enzyme gene (COX-1-10aa-PGIS), cyclooxygenase-1 (COX-1) synthase (PGIS) linked with 10-amino linker....

10.1021/bi101654w article EN Biochemistry 2011-01-20

10.1074/jbc.272.6.3657 article EN cc-by Journal of Biological Chemistry 1997-02-01

The three-dimensional structure of a synthetic peptide corresponding to the N-terminal membrane anchor domain (residues 1—25) prostaglandin I2 synthase (also known as cytochrome P450 8A1), an eicosanoid-synthesizing microsomal P450, has been determined by two-dimensional 1H NMR spectroscopy in trifluoroethanol and dodecylphosphocholine which mimic hydrophobic environment. A combination experiments, including NOESY, TOCSY double-quantum-filtered COSY, was used obtain complete assignments for...

10.1042/bj20021001 article EN Biochemical Journal 2002-12-15

To overcome the difficulty of characterizing structures extracellular loops (eLPs) G protein‐coupled receptors (GPCRs) other than rhodopsin, we have explored a strategy to generate three‐dimensional structural model for GPCR, thromboxane A 2 receptor. This structure was completed by assembly NMR computation‐guided constrained peptides that mimicked and connected conserved seven transmembrane domains. The structure‐based reveals features eLPs, in which second loop (eLP ) disulfide bond...

10.1111/j.1432-1033.2004.04232.x article EN European Journal of Biochemistry 2004-06-23

It remains a challenge to achieve the stable and long-term expression (in human cell lines) of previously engineered hybrid enzyme [triple-catalytic (Trip-cat) enzyme-2; Ruan KH, Deng H & So SP (2006) Biochemistry45, 14003-14011], which links cyclo-oxygenase isoform-2 (COX-2) prostacyclin (PGI(2)) synthase (PGIS) for direct conversion arachidonic acid into PGI(2) through enzyme's Trip-cat functions. The upregulation biosynthesis vascular protector, PGI(2), in cells is an ideal model...

10.1111/j.1742-4658.2008.06703.x article EN FEBS Journal 2008-11-11

Prostacyclin (PGI2) is a potent vasodilator and important mediator of vascular homeostasis; however, its clinical use limited because short (<2-min) half-life. Thus, we hypothesize that the engineered endothelial progenitor cells (EPCs) constitutively secrete high levels PGI2 may overcome this limitation therapy. A cDNA encoding COX-1-10aa-PGIS, which links human cyclooxygenase-1 (COX-1) to prostacyclin synthase (PGIS), was delivered via nucleofection into outgrowth EPCs derived from rat...

10.1002/jcp.23035 article EN Journal of Cellular Physiology 2011-09-21

A 3-D model of human thromboxane A2 synthase (TXAS) was constructed using a homology modeling approach based on information from the 2.0 Å crystal structure hemoprotein domains cytochrome P450BM-3 and P450cam. is bacterial fatty acid monooxygenase resembling eukaryotic microsomal P450s in primary function. TXAS shares 26.4% residue identity 48.4% similarity with domain. The score between much higher than that Alignment domain or P450cam determined through sequence searches. main-chain...

10.1093/protein/7.11.1345 article EN Protein Engineering Design and Selection 1994-01-01

Human thromboxane A2 synthase (TXAS) exhibits spectral characteristics of cytochrome P450 but lacks monooxygenase activity. Its distinctive amino acid sequence makes TXAS the sole member family 5 in superfamily. To better understand structure-function relationship this unusual P450, we have recently constructed a three-dimensional model for using P450BM-3 as template (Ruan, K.-H., Milfeld, K., Kulmacz, R. J., and Wu, K. (1994) Protein Eng. 7, 1345-1551) identified potential active site...

10.1074/jbc.271.33.19970 article EN cc-by Journal of Biological Chemistry 1996-08-01

A retroviral vector (BAG) was used to transfer human prostaglandin H synthase (PGHS-1) gene into a endothelial cell line for enhancement of PGI2 synthesis. Cells infected with BAG containing PGHS-1 cDNA in the sense orientation relative promoter (PGHS(S)) expressed 30-fold increase mRNA but, due reading frame shift, did not show an PGHS protein or synthesis, while those reverse viral (PGHS(R)), produced > 10-fold over control (169 +/- 22 vs 14.8 1.2 amol/micrograms RNA) concordant (5.82 1.07...

10.1172/jci116398 article EN Journal of Clinical Investigation 1993-04-01
Coming Soon ...